Corporate News     09-Mar-24
Alembic Pharma's oncology formulation facility undergoes USFDA audit
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) has conducted an inspection at its Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from 28 February 2024 to 8 March 2024. The US FDA issued a Form 483 with four procedural observations.

The Company will provide comprehensive response to USFDA for the observations within the stipulated period.

Previous News
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
  Market near day's high; metal shares rally for 3rd day
 ( Market Commentary - Mid-Session 01-Jul-24   12:34 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
  Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
 ( Results - Announcements 05-May-23   17:32 )
  Board of Alembic Pharmaceuticals recommends Final Dividend
 ( Corporate News - 05-May-23   17:26 )
  Alembic Pharma says USFDA clears Karakhadi facility
 ( Hot Pursuit - 13-Mar-23   09:35 )
  Alembic Pharmaceuticals' derma unit at Karakhadi clears USFDA inspection
 ( Corporate News - 13-Mar-23   09:08 )
  Alembic Pharmaceuticals reclassifies Dividend
 ( Corporate News - 06-Aug-22   10:31 )
  Alembic Pharma subsidiary receives final approval for lidocaine cream
 ( Hot Pursuit - 12-Apr-22   10:57 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top